Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Rohto Pharmaceutical Co ( (JP:4527) ) just unveiled an announcement.
Rohto Pharmaceutical Co., Ltd. announced a resolution to pay dividends from retained earnings, with a record date of March 31, 2025. The year-end dividend per share is set at 20 yen, consistent with the most recent forecast, and represents an increase from the previous fiscal year’s 15 yen per share. This decision reflects the company’s strong financial performance and commitment to returning value to shareholders, potentially enhancing its market position and investor confidence.
The most recent analyst rating on (JP:4527) stock is a Buy with a Yen4770.00 price target. To see the full list of analyst forecasts on Rohto Pharmaceutical Co stock, see the JP:4527 Stock Forecast page.
More about Rohto Pharmaceutical Co
Rohto Pharmaceutical Co., Ltd. operates in the pharmaceutical industry, focusing on the development and distribution of healthcare and skincare products. The company is known for its innovative solutions in over-the-counter medicines and cosmetics, catering to a global market.
YTD Price Performance: -25.44%
Average Trading Volume: 1,432,605
Technical Sentiment Signal: Sell
Current Market Cap: Yen493.8B
See more insights into 4527 stock on TipRanks’ Stock Analysis page.